(Q79157581)
Statements
Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia? (English)
Subramaniyam S
Nandula SV
Nichols G
Weiner M
Satwani P
Alobeid B
28 September 2006